ライフサイエンスコーパス: ground glass

1 th a solid component 5 mm or larger, or pure ground glass.

2 On high-resolution computed tomography scan, ground-glass and poorly defined nodules, with patchy are

3 mining the optimal duration of follow-up for ground-glass and semisolid opacities; establishing the r

4 es (no solid component) and part-solid (both ground-glass and solid components).

5 bsolid nodules, including the extent of both ground-glass and solid components, as well as accurate a

6 of nodules were solid, 33% (41 of 126) were ground glass, and 24% (30 of 126) were subsolid.

7 ormed on the entire cohort and on the solid, ground-glass, and mixed lesion subgroups.

8 An abdominal radiograph revealed a ground glass appearance with radiolucency outlining the

9 ed as no apparent tissue-level perfusion (no ground-glass appearance of blush or opacification of the

10 cted, dyspnea on exertion, and presence of a ground-glass appearance on high-resolution computed tomo

11 ntent of the assay was to test nonhemolytic, ground-glass-appearing bacterial B. anthracis-like colon

12 he lung show more or less extensive areas of ground-glass, as single pattern or with parenchymal cons

13 A larger MAE was noted for nodules with ground-glass attenuation (2.3 mm(3)) versus those with s

14 nchymal lung disease took the form of either ground-glass attenuation (n = 1) or nodules following pe

15 bronchioloalveolar carcinoma (BAC) (n = 9), ground-glass attenuation (n = 6, 67%) and smooth (n = 3,

16 Forty synthetic nodules (20 with ground-glass attenuation and 20 with solid attenuation)

17 were evaluated for nodules, masses, areas of ground-glass attenuation or of hazy increased attenuatio

18 of compression was greater for nodules with ground-glass attenuation than for those with higher atte

19 ate: the K(W) for nodules, septal lines, and ground-glass attenuation were 0.53, 0.44, and 0.53, resp

20 Interlobular septal thickening and ground-glass attenuation were present on CT scans in two

21 0 nodules with solid attenuation and 20 with ground-glass attenuation) of known volume.

22 ncalcified, and 15 subsolid nodules (13 with ground-glass attenuation).

23 level of 20:1 was 34.9 mm3 for nodules with ground-glass attenuation, compared with 8.3 mm3 for high

24 mpressed images, especially for nodules with ground-glass attenuation.

25 e patterns characterized were: honeycombing, ground glass, bronchovascular, nodular, emphysemalike, a

26 e contributing factor in the pathogenesis of ground-glass cells, which are hepatocytes containing non

27 ysema, airway abnormality, the percentage of ground glass component and the type of tumor margin.

28 pe status for EGFR while the presence of any ground glass component indicates EGFR mutations.

29 .3; P < .001) alone or in combination with a ground-glass component (OR, 24; P < .001).

30 ndependently scored by four radiologists for ground glass (CT-alv) and linear opacity (CT-fib) on a s

31 f lung diseases: septal, reticular, nodular, ground-glass, cystic, and consolidations.

32 Computed tomography scan showed patchy ground glass density, thickened bronchial walls, and bil

33 rafish of 5.1 millimeters in thickness and a ground glass diffuser.

34 Ground-glass (GG) inclusions within hepatocytes are an i

35 Proportion of lung occupied by ground glass, ground glass-reticular (GGR), honeycombing

36 Ground-glass hepatocellular inclusions (positive with pe

37 A malignant nodule that is entirely ground glass in appearance is typically slow growing.

38 terstitial infiltrate) and two on CT scans ("ground-glass"), incorporating mandatory variables: lacta

39 diffusing capacity for carbon monoxide, and ground glass infiltrate and fibrosis on high resolution

40 city for carbon monoxide, and an increase in ground glass infiltrates (p < or = 0.08) compared with p

41 ined to the tip of the outer capillary via a ground-glass joint.

42 ) and define abnormal low (n = 15) and high (ground-glass) (n = 8) lung attenuation.

43 (peribronchial markings, consolidation, and ground-glass, nodular, and reticular opacity), distribut

44 cancer screening who were assumed to have a ground-glass nodule (GGN) at baseline.

45 Subsolid pulmonary nodules, comprising pure ground-glass nodules (GGNs) and part-solid nodules (PSNs

46 gies and treatment options for patients with ground-glass nodules (GGNs) by using decision-analysis m

47 es involving perifissural nodules (PFNs) and ground-glass nodules (GGNs) now designated as a negative

48 Of 141 SSNs, there were 57 pure ground-glass nodules (GGNs), 22 heterogeneous GGNs, and

49 Subsolid nodules are divided into ground-glass nodules (no solid component) and part-solid

50 s that the follow-up interval for evaluating ground-glass nodules can be increased from 1 year to 3 y

51 The increase in allowable nodule size for ground-glass nodules in category 2 from 20 mm (version 1

52 Conclusion Treatment of pure ground-glass nodules was not cost-effective.

53 stimated by differentiating CT follow-up for ground-glass nodules, solid nodules 8 mm or smaller, and

54 Visible ground glass opacification indicated diffuse alveolar ha

55 contrast CT demonstrated nonspecific diffuse ground glass opacification, most prominent within the up

56 abnormalities in 41 participants (56%), with ground-glass opacification (35 of 73 participants [48%])

57 In ARDSP, ground-glass opacification and consolidation were equall

58 scans were evaluated in a blinded manner for ground-glass opacification and fibrosis in the lavaged l

59 ingula there was excellent agreement between ground-glass opacification and the finding of alveolitis

60 The proportion of ground-glass opacification at CT was similar in patients

61 Similarly, while ground-glass opacification on HRCT accurately predicted

62 99% of discharged patients had reduced ground-glass opacification on repeat CT imaging, and nor

63 and characterized by a greater proportion of ground-glass opacification than that in patients with IP

64 n were equally prevalent, whereas in ARDSEXP ground-glass opacification was dominant.

65 Ground-glass opacification was evenly distributed, where

66 resence of features such as honeycombing and ground-glass opacification, and classification based on

67 CT extent (+/-SD) of normally aerated lung, ground-glass opacification, and dense parenchymal opacif

68 On CT, neovascularity, lobular ground-glass opacification, and hilar and intercostal sy

69 ry vessels, termed "neovascularity," lobular ground-glass opacification, and systemic perihilar and i

70 ity-defined functional small airway disease, ground-glass opacification, bronchovascular prominence,

71 The extent of interstitial lung disease, ground-glass opacification, emphysema, and the coarsenes

72 Ex vivo CT demonstrated ground-glass opacification, reticulation, and bronchiect

73 asymmetric, with a mix of consolidation and ground-glass opacification, whereas ARDSEXP has predomin

74 solidation, whereas ARDSEXP caused symmetric ground-glass opacification.

75 whereas ARDSEXP has predominantly symmetric ground-glass opacification.

76 The main manifestations on chest CT were ground glass opacities (31.4%), ground glass opacities a

77 The residual lesions mainly presented as ground glass opacities (61.0%), and the main accompanyin

78 sed as a percentage) and mean attenuation of ground glass opacities (GGO) and consolidation were quan

79 terlobular septal thickening (ILST;100%) and ground glass opacities (GGOs; 91.7%), resulting in crazy

80 The most common chest CT findings were ground glass opacities (three of five), with mild to mod

81 hest CT were ground glass opacities (31.4%), ground glass opacities and consolidation (20.3%), ground

82 d glass opacities and consolidation (20.3%), ground glass opacities and reticular patterns (32.2%), m

83 re classified into; pulmonary signs of which ground glass opacities are considered the characteristic

84 Localization of subcentimeter ground glass opacities during minimally invasive thoraco

85 X-ray showed multiple patchy ground glass opacities in both lungs.

86 st computed tomography on admission revealed ground glass opacities in the right upper and lower lung

87 A total of 50.2% of group 1 PH subjects had ground glass opacities on chest computed tomography.

88 spectively; unexpected, frequent presence of ground glass opacities on computed tomography; and sleep

89 imaging findings may also be seen alongside ground glass opacities, based on the degree of disease p

90 mediate changes manifesting as peribronchial ground glass opacities, consolidations, air-trapping, an

91 score (>= 25%) and CT patterns (presence of ground glass opacities, consolidations, crazy paving are

92 The most common imaging finding was ground glass opacities, followed by septal thickening.

93 c PAP was interlobular septal thickening and ground glass opacities, resulting in crazy-paving patter

94 CT showed centrilobular granular shadow and ground glass opacities.

95 ed diffuse 1- to 2-mm pulmonary nodules with ground-glass opacities ( Fig 1 ).

96 The findings of the 62 readings were: ground-glass opacities (100%), reticulation (83%), subpl

97 uted tomography images revealed cysts (76%), ground-glass opacities (73%), emphysema (49%), and retic

98 Pulmonary focal Ground-glass Opacities (fGGOs) would frequently be ident

99 Predominant CT observations were ground-glass opacities (GGO) (59/70 lobes examined) and

100 1 lobe (75%; 95% CI: 0.68-0.82; p < 0.001), ground-glass opacities (GGO) (73%; 95% CI: 0.67-0.78; p

101 Compared with the non-critical group, mixed ground-glass opacities (GGO) and consolidation lesion, p

102 nfection presented consistent indications of ground-glass opacities (GGO), consolidation, and interlo

103 y-four percent (113/120) of the patients had ground-glass opacities (GGO).

104 cal CT features are bilateral and multilobar ground-glass opacities (GGO).

105 Ground-glass opacities (GGOs) are a non-specific high-re

106 Rationale: Ground-glass opacities (GGOs) in the absence of intersti

107 Sensitivity and PPV for the detection of ground-glass opacities (GGOs) were 77.7% and 53.8%, resp

108 Diffuse disease, including ground-glass opacities (k = 0.57) and tree-in-bud nodule

109 Initial CT scans identified ground-glass opacities and bilateral abnormalities as mo

110 The exudative phase would manifest as ground-glass opacities and consolidation, and the prolif

111 ificant relationship between the presence of ground-glass opacities and FEV1/FVC (P < 0.01).

112 Ground-glass opacities and linear bands (10 of 20 partic

113 our hospital due to respiratory failure with ground-glass opacities and mediastinal emphysema on ches

114 The most common findings in FWL were ground-glass opacities and micronodules.

115 from total lung function abnormalities; and ground-glass opacities and reticulation were present in

116 e percentage of residual lung abnormalities (ground-glass opacities and reticulations).

117 I]; 1.03-2.20; P = .033) and the presence of ground-glass opacities at chest high-resolution computed

118 opacities (thickened interlobular septa and ground-glass opacities at CT), cysts or cavities, and fi

119 thology, but with a peripheral alveolar, and ground-glass opacities at lung bases, classic COVID-19 r

120 Ground-glass opacities by radiologist read occurred in 1

121 phy scan showed a diffuse, random pattern of ground-glass opacities in the lungs.

122 sidered to include patchy consolidations and ground-glass opacities in the peribronchial and subpleur

123 d on March 20, 2020 with fever, hypoxia, and ground-glass opacities on chest X-ray.

124 ormalities on computed tomography, including ground-glass opacities or reticulations, lung distortion

125 The presence of nodules, consolidations, and ground-glass opacities was evaluated.

126 frequently in the early phase (25%), whereas ground-glass opacities were more common in the intermedi

127 ipants with positive RT-PCR and CT findings, ground-glass opacities were present in all 58 (100%), bo

128 Whereas ground-glass opacities were the most common characterist

129 -19 pneumonia in Rome, Italy, was peripheral ground-glass opacities with multilobe and posterior invo

130 atelectasis/consolidation plus total MP plus ground-glass opacities), and total disease (i.e., all it

131 re airspace opacities (consolidations and/or ground-glass opacities), which are typically bilateral,

132 a, focal consolidation, reticular opacities, ground-glass opacities, and cysts or cavities.

133 o-nodules, consolidations, cavitary lesions, ground-glass opacities, and miliary nodules.

134 reas of consolidation, often associated with ground-glass opacities, are the predominant radiographic

135 s plugging (MP), airway wall thickening, MP, ground-glass opacities, bullae, airways, and parenchyma.

136 by exposure identification, HRCT findings of ground-glass opacities, centrilobular nodules, and mosai

137 jury is characterized by bilateral symmetric ground-glass opacities, consolidation, and a lower lobe

138 CT features recorded included ground-glass opacities, consolidation, micronodules, ret

139 Among other radiologic findings, we analyzed ground-glass opacities, consolidations, linear opacities

140 While ground-glass opacities, micronodules, or both were found

141 pants showed subtle subpleural reticulation, ground-glass opacities, or both, and 18 of 91 (20%) part

142 fusion, atelectasis, emphysema, infiltrates, ground-glass opacities, or pneumothorax.

143 nd 18 of 91 (20%) participants had extensive ground-glass opacities, reticulations, bronchial dilatio

144 in 108 of 171 patients (63%), mainly subtle ground-glass opacities.

145 r presentations, including consolidation and ground-glass opacities.

146 l lines were thickened in 7.3%, and 7.3% had ground-glass opacities.

147 -19 are bilateral and peripheral predominant ground-glass opacities.

148 Descriptors include "mosaic" attenuation and ground-glass opacities.

149 comparison to CT, MR imaging depicted 75% of ground-glass opacities.

150 reas of consolidation, often associated with ground-glass opacities.

151 nchiectasis (48%), pleural thickening (40%), ground glass opacity (32%), mass-like consolidation (20%

152 with severe lymphocytopenia or an extent of ground glass opacity (GGO) >50% on chest computed tomogr

153 ted tomography (CT) findings mainly included ground glass opacity (GGO) (93.3%), inter-lobular septal

154 ed each CXR in consensus for: consolidation, ground glass opacity (GGO), location and pleural fluid.

155 lung, overall opacity and opacity subtypes (ground glass opacity [GGO] and consolidation) were extra

156 Extent of ground glass opacity and lung fibrosis were assessed vis

157 of CT features (including reticular pattern, ground glass opacity, and thin-walled cystic air spaces)

158 ed to single non-fibrotic changes, including ground glass opacity, consolidations, nodules/masses, pa

159 subglottic airway fluid (92%), and pulmonary ground-glass opacity (100%) but did not have evidence of

160 Overall, the most common CT findings were ground-glass opacity (114 of 119, 96%) and consolidation

161 error group, the percentages of nodules with ground-glass opacity (91%) or judged to be subtle (91%)

162 ents will have CT abnormalities that include ground-glass opacity (GGO) and subpleural bands with con

163 ervised machine learning to measure regional ground-glass opacity (GGO) and using inspiratory and exp

164 children is relatively high (658/987), with ground-glass opacity (GGO) being the most prevalent feat

165 The most common HRCT presentation of COP was ground-glass opacity (GGO) in 83.9% of cases, followed b

166 The location and extent of ground-glass opacity (GGO) was compared with symptoms an

167 d specificity of the abnormal chest CT scan, ground-glass opacity (GGO), consolidation opacity, and b

168 The imaging features analyzed were ground-glass opacity (GGO), consolidation, pleuroparench

169 Bilateral lung involvement, pure ground-glass opacity (GGO), mixed (GGO pulse consolidati

170 lities that included airspace consolidation, ground-glass opacity (GGO), reticulation, honeycombing,

171 oking-related lung diseases characterized by ground-glass opacity and centrilobular nodules.

172 Measurements and Main Results: Increasing ground-glass opacity and decreasing lung volume showed c

173 ignificantly correlated with the presence of ground-glass opacity and irregular nodules or nodules wi

174 Chest computed tomography showed ground-glass opacity and some centrilobular nodules.

175 ury pattern at CT, manifesting as multifocal ground-glass opacity and/or consolidation, typically mul

176 NSIP is characterized by predominantly basal ground-glass opacity and/or reticular pattern, often wit

177 omogeneous attenuation was classified as (a) ground-glass opacity due to infiltrative disease, (b) mo

178 Chest radiographic findings included ground-glass opacity in 14 of 14 (100%) and consolidatio

179 CT findings included ground-glass opacity in 14 of 14 (100%), consolidation i

180 uencies of developing lung adenocarcinoma or ground-glass opacity lung lesions than those who do not

181 thy fluid in the airways, pulmonary opacity (ground-glass opacity or airspace consolidation), interlo

182 resence of patchy and/or confluent, bandlike ground-glass opacity or consolidation in a peripheral an

183 ients hospitalized for severe COVID-19, with ground-glass opacity pneumonia and arterial partial oxyg

184 LIP is associated with a CT pattern of ground-glass opacity sometimes associated with perivascu

185 Ground-glass opacity was the most common radiological fi

186 (89%) of the drowning subjects had pulmonary ground-glass opacity with septal lines, which was mild w

187 subglottic tracheal and bronchial fluid, and ground-glass opacity within the lung at multidetector CT

188 anasal sinuses and mastoid air cells and had ground-glass opacity within the lungs.

189 diographic features from HRCT scans included ground-glass opacity, consolidation, air bronchogram, no

190 ed that stepwise progression of lesions with ground-glass opacity, manifested as an increase in size

191 construct validity of HRCT-reported nodules, ground-glass opacity, or other typical findings.

192 eral lung involvement, subpleural reticulum, ground-glass opacity, peripheral lung lesions, and bronc

193 nspicuity scores (a) improved in group 2 for ground-glass opacity, reticulation, and bronchiectasis a

194 cavitating nodules to lobar consolidation to ground-glass opacity.

195 manifests as diffuse lung consolidation and ground-glass opacity.

196 circulation, resolution of the parenchymal "ground glass" opacity and absence of further episodes of

197 walls of numerous bronchial branches and a "ground glass" opacity in the anterior segment of the rig

198 Tree-in-bud, ground-glass-opacity, bronchiectasis, cicatricial emphys

199 CT images; tumors were classified as solid, ground glass, or mixed.

200 The predominant CT finding was the ground-glass pattern (n=110; 60.4%), the most common dis

201 tastases, reinforcing the indolent nature of ground glass predominant adenocarcinoma and suggesting t

202 Ground-glass pulmonary nodules have a probability of mal

203 Proportion of lung occupied by ground glass, ground glass-reticular (GGR), honeycombing, emphysema, a

204 Chest X-ray showed diffuse ground-glass shadows in both lungs.